N-stearoyl-l-tyrosine ameliorates sevoflurane induced neuroapoptosis via MEK/ERK1/2 MAPK signaling pathway in the developing brain

Neuroscience Letters

Volumn 541, Issue , 2013, Pages 167-172

  Wang, Wen Yuan ^a   Yang, Rui ^b   Hu, Shuang Fei ^a   Wang, Hua ^b   Ma, Zheng Wen ^b   Lu, Yang ^b  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; ERK1 2 signaling; Hippocampus; Learning and memory; N stearoyl l tyrosine; Sevoflurane

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N STEAROYL LEVO TYROSINE; NEUROPROTECTIVE AGENT; PROTEIN BCL 2; SEVOFLURANE; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LEARNING; LOCOMOTION; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANESTHETICS, INHALATION; ANIMALS; APOPTOSIS; BRAIN; CELL SURVIVAL; CELLS, CULTURED; EMBRYO, NONMAMMALIAN; LEARNING DISORDERS; MAP KINASE SIGNALING SYSTEM; MAZE LEARNING; MEMORY DISORDERS; METHYL ETHERS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TYROSINE;

EID: 84876406811     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.02.041     Document Type: Article

References (29)

1. Allan L.A., Morrice N., Brady S., Magee G., Pathak S., Clarke P.R. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat. Cell Biol. 2003, 5:647-654.
2. Alonso M., Medina J.H., Pozzo-Miller L. ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn. Mem. 2004, 11:172-178.
3. Bahr B.A., Karanian D.A., Makanji S.S., Makriyannis A. Targeting the endocannabinoid system in treating brain disorders. Expert Opin. Investig. Drugs 2006, 15:351-365.
4. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
5. Ding Q., Wang Q., Deng J., Gu Q., Hu S., Li Y., Su B., Zeng Y., Xiong L. Sevoflurane preconditioning induces rapid ischemic tolerance against spinal cord ischemia/reperfusion through activation of extracellular signal-regulated kinase in rabbits. Anesth. Analg. 2009, 109:1263-1272.
6. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Hum. Dev. 1979, 311:79-83.
7. Fernández-Ruiz J., Berrendero F., Hernández M.L., Ramos J.A. The endogenous cannabinoid system and brain development. Trends Neurosci. 2000, 23:14-20.
8. Hauer D., Ratano P., Morena M., Scaccianoce S., Briegel I., Palmery M., Cuomo V., Roozendaal B., Schelling G., Campolongo P. Propofol enhances memory formation via an interaction with the endocannabinoid system. Anesthesiology 2011, 114:1380-1388.
9. Jevtovic-Todorovic V., Hartman R.E., Izumi Y., Benshoff N.D., Dikranian K., Zorumski C.F., Olney J.W., Wozniak D.F. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J. Neurosci. 2003, 23:876-882.
10. Jiang W., Zhang Y., Xiao L., Van Cleemput J., Ji S., Bai G., Zhang X. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic-and antidepressant-like effects. J. Clin. Invest. 2005, 115:3104-3116.
11. Kaech S., Banker G. Culturing hippocampal neurons. Nat. Protoc. 2006, 1:2406-2415.
12. Lin Q., Hai J., Yao L.Y., Lu Y. Neuroprotective effects of NSTyr on cognitive function and neuronal plasticity in rats of chronic cerebral hypoperfusion. Brain Res. 2010, 1325:183-190.
13. Lutz B. The endocannabinoid system and extinction learning. Mol. Neurobiol. 2007, 36:92-101.
14. Ma D., Williamson P., Januszewski A., Nogaro M.C., Hossain M., Ong L.P., Shu Y., Franks N.P., Maze M. Xenon mitigates isoflurane-induced neuronal apoptosis in the developing rodent brain. Anesthesiology 2007, 106:746-753.
15. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgansberger W. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
16. Micale V., Mazzola C., Drago F. Endocannabinoids and neurodegenerative diseases. Pharmacol. Res. 2007, 56:382-392.
17. Riccio A., Ahn S., Davenport C.M., Blendy J.A., Ginty D.D. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 1999, 286:2358-2361.
18. Satomoto M., Satoh Y., Terui K., Miyao H., Takishima K., Ito M., Imaki J. Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology 2009, 110:628-637.
19. Shu Y., Patel S.M., Pac-Soo C., Fidalgo A.R., Wan Y., Maze M., Ma D. Xenon pretreatment attenuates anesthetic-induced apoptosis in the developing brain in comparison with nitrous oxide and hypoxia. Anesthesiology 2010, 113:360-368.
20. Sjöström P.J., Rancz E.A., Roth A., Häusser M. Dendritic excitability and synaptic plasticity. Physiol. Rev. 2008, 88:769-840.
21. Straiko M.M., Young C., Cattano D., Creeley C.E., Wang H., Smith D.J., Johnson S.A., Li E.S., Olney J.W. Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology 2009, 110:862-868.
22. Tamura Y., Simizu S., Osada H. The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria. FEBS Lett. 2004, 569:249-255.
23. Wang W.Y., Wang H., Luo Y., Jia L.J., Zhao J.N., Zhang H.H., Ma Z.W., Xue Q.S., Yu B.W. The effects of metabotropic glutamate receptor 7 allosteric agonist N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride on developmental sevoflurane neurotoxicity: role of extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase signaling pathway. Neuroscience 2012, 205:167-177.
24. Yang Z., Sun K., Suo W., Yao L., Fu Q., Cui Y., Fu G., Chen H., Lu Y. N-stearoyltyrosine protects primary neurons from A [beta]-induced apoptosis through modulating mitogen-activated protein kinase activity. Neuroscience 2010, 169:1840-1847.
25. Yao L.Y., Lin Q., Niu Y.Y., Deng K.M., Zhang J.H., Lu Y. Synthesis of lipoamino acids and their activity against cerebral ischemic injury. Molecules 2009, 14:4051-4064.
26. Yon J.H., Daniel-Johnson J., Carter L.B., Jevtovic-Todorovic V. Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience 2005, 135:815-827.
27. Yuan J., Yankner B.A. Apoptosis in the nervous system. Nature 2000, 407:802-809.
28. Zhang Y., Dong Y., Wu X., Lu Y., Xu Z., Knapp A., Yue Y., Xu T., Xie Z. The mitochondrial pathway of anesthetic isoflurane-induced apoptosis. J. Biol. Chem. 2010, 285:4025-4037.
29. Zhang Y.B., Kan M.Y., Yang Z.H., Ding W.L., Yi J., Chen H.Z., Lu Y. Neuroprotective effects of N-stearoyltyrosine on transient global cerebral ischemia in gerbils. Brain Res. 2009, 1287:146-156.